Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000627251 | SCV000748242 | likely pathogenic | not provided | 2018-04-20 | criteria provided, single submitter | clinical testing | The L103X variant in the HESX1 gene has been reported previously in the heterozygous state in a child with septo-optic dysplasia, however, no clinical information was provided and it is unknown if the variant was associated with autosomal dominant or recessive inheritance (Mueller et al., 2010). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The L103X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). We interpret L103X as a likely pathogenic variant. |
Ce |
RCV000627251 | SCV001246951 | likely pathogenic | not provided | 2019-07-01 | criteria provided, single submitter | clinical testing | |
Clinical Molecular Genetics Laboratory, |
RCV000581553 | SCV000692275 | pathogenic | Septo-optic dysplasia sequence | 2009-06-22 | no assertion criteria provided | clinical testing | |
Clinical Molecular Genetics Laboratory, |
RCV000582144 | SCV000692276 | pathogenic | Pituitary hormone deficiency, combined, 1 | 2009-06-22 | no assertion criteria provided | clinical testing |